NKG2A blocks the anti-metastatic functions of natural killer cells

Florent Carrette1, Eric Vivier2

  • 1Innate Pharma Research Laboratories, Innate Pharma, Marseille, France.

Cancer Cell
|February 14, 2023
PubMed

Insights

Pancreatic cancer liver metastasis is a major challenge. Researchers found that circulating tumor cells in the hepatic portal vein evade natural killer cells via the NKG2A/HLA-E pathway, suggesting a new therapeutic target.

Area of Science:

  • Oncology
  • Immunology
  • Cancer Metastasis

Background:

  • Pancreatic ductal adenocarcinoma (PDAC) liver metastasis poses a significant clinical challenge.
  • Understanding the mechanisms of immune evasion by circulating tumor cells (CTCs) is crucial for developing effective therapies.

Purpose of the Study:

  • To investigate the immune evasion mechanisms of PDAC-derived CTCs in the hepatic portal vein (HPV).
  • To identify the specific molecular pathways involved in protecting CTCs from natural killer (NK) cell-mediated lysis.

Main Methods:

  • Analysis of CTCs isolated from the HPV of PDAC patients.
  • Assessment of NK cell cytotoxicity against CTCs.
  • Investigation of the role of the NKG2A/HLA-E axis in immune evasion.

Main Results:

  • PDAC-derived CTCs in the HPV, but not from primary or other metastatic sites, are protected from NK cell attack.
  • This protection is mediated by the interaction between NKG2A on NK cells and HLA-E expressed by CTCs.
  • Blocking the NKG2A/HLA-E pathway restores NK cell-mediated killing of CTCs.

Conclusions:

  • The NKG2A/HLA-E axis is a key mechanism for PDAC CTC immune evasion in the liver.
  • Targeting this pathway represents a promising therapeutic strategy to prevent or treat PDAC liver metastasis.

Related Concept Videos

Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
1.9K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.1K
Immune Surveillance by NK Cells and Phagocytes01:25

Immune Surveillance by NK Cells and Phagocytes

Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
1.6K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
230
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K